COVINA, CA -- (MARKET WIRE) -- December 11, 2006 -- Healtheuniverse Inc. (PINKSHEETS: HLUN), a biotechnology development firm specializing in the development and commercialization of biopharmaceutical and biomedical products, announced today that intellectual property in development is moving toward a progenitor cell line that is proprietary to the Company. This seminal research will lead to the development of various cell lines that will be utilized to cultivate cells to form functional human tissue or substitutes. These unique cell lines offer an alternative to human embryonic stem cells for medical treatments avoiding the destruction of embryos.
